Brief: Senzime Says ASA Approves Guidelines For Neuromuscular Blockade Monitoring
Oct 27 (Reuters) - Senzime AB (publ) SEZI.ST :
* NEW US CLINICAL GUIDELINES WILL RECOMMEND SENZIME'S TYPE
OF
TECHNOLOGY FOR PATIENT MONITORING
* AMERICAN SOCIETY OF ANESTHESIOLOGISTS (ASA) HAS VOTED ON
FINAL
APPROVAL OF CLINICAL GUIDELINES FOR MONITORING AND REVERSAL OF
NEUROMUSCULAR BLOCKADE
Source text for Eikon: ID:nMFNbZ7dKH
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract